Virginia Retirement Systems’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,900
Closed -$379K 1100
2021
Q1
$379K Buy
11,900
+1,000
+9% +$24.3K ﹤0.01% 943
2020
Q4
$249K Buy
10,900
+1,100
+11% +$25.3K ﹤0.01% 1014
2020
Q3
$247K Sell
9,800
-1,400
-13% -$38.2K ﹤0.01% 978
2020
Q2
$313K Buy
+11,200
New +$195K ﹤0.01% 938
2019
Q1
Sell
-23,900
Closed -$304K 1099
2018
Q4
$304K Buy
+23,900
New +$401K ﹤0.01% 990

Other funds holding MGNX

Virginia Retirement Systems's MGNX Position: Q2 2021 in Review

Virginia Retirement Systems sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 11,900 shares — an estimated $379K sold.

Virginia Retirement Systems first reported a position in MGNX in Q4 2018 and held it in 5 quarters. The position peaked at $379K in Q1 2021. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Virginia Retirement Systems reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Virginia Retirement Systems sold 11,900 MacroGenics shares in Q2 2021, an estimated $379K.
  • Virginia Retirement Systems first reported a position in MacroGenics in Q4 2018 and held it in 5 quarters.
  • Virginia Retirement Systems's MacroGenics position peaked at $379K in Q1 2021.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Virginia Retirement Systems's 13F filing for Q2 2021, filed 13 Aug 2021.